{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:42:14Z","timestamp":1791214934747,"version":"4.1.0"},"reference-count":19,"publisher":"Informa Healthcare","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1185\/030079906x162719","type":"journal-article","created":{"date-parts":[[2006,12,16]],"date-time":"2006-12-16T16:15:36Z","timestamp":1166285736000},"page":"175-184","source":"Crossref","is-referenced-by-count":91,"title":["A retrospective pooled analysis of duloxetine safety in 23\u2009983 subjects"],"prefix":"10.1185","volume":"23","author":[{"given":"James","family":"Gahimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Wernicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilker","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Ossanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Wulster-Radcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Viktrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2006,12,14]]},"reference":[{"key":"CIT0001","first-page":"116","volume":"1","author":"Duloxetine Eli Pitsikas N.","year":"2000","journal-title":"Curr Opin Investig Drugs"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-0348-8183-8_5"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ne.07.030184.001521"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(93)90210-E"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1017\/S0140525X97251484","volume":"20","author":"Coderre TJ","year":"1997","journal-title":"Behav Brain Sci"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15378.x"},{"key":"CIT0009","first-page":"47","volume":"59","author":"Krier J","year":"1979","journal-title":"Effects of clonidine on the lumbar sympathetic pathways to the large intestine and urinary bladder of the cat. Eur J Pharmacol"},{"key":"CIT0010","first-page":"107","volume":"61","author":"Pedersen E","year":"1980","journal-title":"Effect of the alpha-adrenergic blocking agent thymoxamine on the neurogenic bladder and urethra. Acta Neurol Scand"},{"key":"CIT0011","first-page":"403","volume":"132","author":"Gajewski J","year":"1984","journal-title":"Experimental evidence for a central nervous system site of action in the effect of alpha-adrenergic blockers on the external urinary sphincter. J Urol"},{"key":"CIT0012","first-page":"352","volume":"246","author":"Downie JW","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2005.08.006"},{"key":"CIT0015","first-page":"346","volume":"6","author":"Raskin J","year":"2005","journal-title":"A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med"},{"key":"CIT0016","first-page":"5","volume":"119","author":"Arnold LM","year":"2005","journal-title":"A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1002\/hup.696"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199920030-00007"},{"key":"CIT0020","first-page":"116","volume":"24","author":"Bump R","year":"2005","journal-title":"The effect of duloxetine dose escalation and tapering on the incidence of adverse events (AE) in women with stress urinary incontinence. Neurourol Urodyn"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2005.12.003"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052270"},{"key":"CIT0023","first-page":"587","volume":"26","author":"Acharya N","year":"2006","journal-title":"Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder. J Clin Psychopharmacol"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079906X162719","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T02:13:02Z","timestamp":1555985582000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079906X162719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,14]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2006,11,22]]},"published-print":{"date-parts":[[2007,1]]}},"alternative-id":["10.1185\/030079906X162719"],"URL":"https:\/\/doi.org\/10.1185\/030079906x162719","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,14]]}}}